James M. Berger | |
---|---|
Born | James Michael Berger 1968 (age 55–56) Albuquerque, New Mexico, U.S. |
Academic background | |
Education | University of Utah (BS) Harvard University (PhD) |
Doctoral advisor | James C. Wang |
Academic work | |
Discipline | Biology,chemistry |
Sub-discipline | Biochemistry,biophysical chemistry |
Institutions | University of California,Berkeley Lawrence Berkeley National Laboratory Johns Hopkins University |
James Michael Berger (born 1968) is an American academic working as a professor of biophysics and biophysical chemistry at Johns Hopkins University School of Medicine,where he is also the co-director of the Cancer Chemical and Structural Biology Program at the Sidney Kimmel Comprehensive Cancer Center and the director of the Johns Hopkins Institute for Basic Biomedical Sciences. His main area of research is the functions of molecular cellular machinery. [1]
Berger was born in 1968 [2] in Albuquerque,New Mexico. Raised in Santa Fe,New Mexico,both of his parents were employed at Los Alamos National Laboratory. In high school,he spent a summer working there,solidifying his interest in biochemistry. [3]
Berger studied biochemistry,with a minor in math,as an undergraduate at the University of Utah. He graduated Phi Beta Kappa and spent summers working at a nuclear research facility. [4] After graduating in 1990,he earned his PhD from Harvard University,where he studied protein crystallography and worked with James C. Wang.
Berger completed a fellowship at the Whitehead Institute,studying topoisomerases from 1995 to 1998. He then became an assistant professor and later professor of biochemistry and molecular biology at the University of California,Berkeley. While employed there,he also worked as a staff research scientist at the Lawrence Berkeley National Laboratory from 1999 to 2013 and served as director of UC Berkeley's Keck Macrolab. In 2013,he moved to Johns Hopkins University.
Berger's lab researches DNA replication and the organization of the enzymes that are involved and the role of ATP in this process. [5]
In 1994,he married Marian Feldman,a professor of Near Eastern Studies,while both were graduate students at Harvard University. [6]
Daniel Nathans was an American microbiologist. He shared the 1978 Nobel Prize in Physiology or Medicine for the discovery of restriction enzymes and their application in restriction mapping.
Marc Wallace Kirschner is an American cell biologist and biochemist and the founding chair of the Department of Systems Biology at Harvard Medical School. He is known for major discoveries in cell and developmental biology related to the dynamics and function of the cytoskeleton,the regulation of the cell cycle,and the process of signaling in embryos,as well as the evolution of the vertebrate body plan. He is a leader in applying mathematical approaches to biology. He is the John Franklin Enders University Professor at Harvard University. In 2021 he was elected to the American Philosophical Society.
Masayori Inouye is a distinguished professor in the department of biochemistry and molecular biology at the Robert Wood Johnson Medical School at Rutgers University. He,along with his team,discovered natural antisense RNA. Inouye was also a key scientist involved in the discovery and characterization of retrons,which are retroviral-like elements found in various bacterial genomes.
Bruce Michael Alberts is an American biochemist and the Chancellor’s Leadership Chair in Biochemistry and Biophysics for Science and Education,emeritus at the University of California,San Francisco. He has done important work studying the protein complexes which enable chromosome replication when living cells divide. He is known as an original author of the "canonical,influential,and best-selling scientific textbook" Molecular Biology of the Cell,and as Editor-in-Chief of Science magazine.
John Norman Abelson is an American molecular biologist with expertise in biophysics,biochemistry,and genetics. He was a professor at the California Institute of Technology (Caltech).
Lubert Stryer is the Emeritus Mrs. George A. Winzer Professor of Cell Biology,at Stanford University School of Medicine. His research over more than four decades has been centered on the interplay of light and life. In 2007 he received the National Medal of Science from President Bush at a ceremony at the White House for elucidating the biochemical basis of signal amplification in vision,pioneering the development of high density microarrays for genetic analysis,and authoring the standard undergraduate biochemistry textbook,Biochemistry. It is now in its tenth edition and also edited by Jeremy Berg,Justin Hines,John L. Tymoczko and Gregory J. Gatto,Jr.
Eva Nogales is a Spanish-American biophysicist at the Lawrence Berkeley National Laboratory and a professor at the University of California,Berkeley,where she served as head of the Division of Biochemistry,Biophysics and Structural Biology of the Department of Molecular and Cell Biology (2015–2020). She is a Howard Hughes Medical Institute investigator.
John Kuriyan is the dean of basic sciences and a professor of biochemistry at Vanderbilt University School of Medicine. He was formerly the Chancellor's Professor at the University of California,Berkeley in the departments of molecular and cell biology (MCB) and chemistry,a faculty scientist in Berkeley Lab's physical biosciences division,and a Howard Hughes Medical Institute investigator. He is a member of the National Academy of Sciences and he has also been on the Life Sciences jury for the Infosys Prize in 2009,2019 and 2020.
James C. Wang is Taiwanese American biochemist and biologist. He is a Harvard University Professor of biochemistry and molecular biology. Wang was the first discoverer of topoisomerases. He was elected as an academician of the Taiwan Academia Sinica in 1982 and a member of the United States National Academy of Sciences.
Jeremy Mark Berg was founding director of the University of Pittsburgh's Institute for Personalized Medicine. He holds positions as Associate Senior Vice Chancellor for Science Strategy and Planning and Professor of Computational and Systems Biology at the University of Pittsburgh. From 2016 to 2019,Berg was editor in chief of the Science journals.
Richard I. Morimoto is a Japanese American molecular biologist. He is the Bill and Gayle Cook Professor of Biology and Director of the Rice Institute for Biomedical Research at Northwestern University.
Thomas Dean Pollard is a prominent educator,cell biologist and biophysicist whose research focuses on understanding cell motility through the study of actin filaments and myosin motors. He is Sterling Professor Emeritus of Molecular,Cellular &Developmental Biology and a professor emeritus of cell biology and molecular biophysics &biochemistry at Yale University. He was dean of Yale's Graduate School of Arts and Sciences from 2010 to 2014,and president of the Salk Institute for Biological Studies from 1996 to 2001.
Thomas Arthur Steitz was an American biochemist,a Sterling Professor of Molecular Biophysics and Biochemistry at Yale University,and investigator at the Howard Hughes Medical Institute,best known for his pioneering work on the ribosome.
Klaus Weber was a German scientist who made many fundamentally important contributions to biochemistry,cell biology,and molecular biology,and was for many years the director of the Laboratory of Biochemistry and Cell Biology at the Max Planck Institute for Biophysical Chemistry in Göttingen,Germany. This institute has been renamed the Max Planck Institute for Multidisciplinary Sciences.
Thomas J. Kelly is an American cancer researcher whose work focuses on the molecular mechanisms of DNA replication. Kelly is director of the Sloan-Kettering Institute,the basic research arm of the Memorial Sloan-Kettering Cancer Center. He holds the Center's Benno C. Schmidt Chair of Cancer Research.
Richard H. Scheller is the former Chief Science Officer and Head of Therapeutics at 23andMe and the former Executive Vice President of Research and Early Development at Genentech. He was a professor at Stanford University from 1982 to 2001 before joining Genentech. He has been awarded the Alan T. Waterman Award in 1989,the W. Alden Spencer Award in 1993 and the NAS Award in Molecular Biology in 1997,won the 2010 Kavli Prize in Neuroscience with Thomas C. Südhof and James E. Rothman,and won the 2013 Albert Lasker Award for Basic Medical Research with Thomas Südhof. He was also given the Life Sciences Distinguished Alumni Award from University of Wisconsin–Madison. He is a Fellow of the American Academy of Arts and Sciences and a Member of the National Academy of Sciences.
Howard Ronald Kaback was an American biochemist,known for Kabackosomes,the cell-free membrane transport vesicles. He was the brother of Michael M. Kaback,pediatrician and human geneticist,who developed a screening program to detect and prevent Tay–Sachs disease,a rare and fatal genetic disorder most common in Ashkenazi Jews.
G. Marius Clore MAE,FRSC,FRS is a British-born,American molecular biophysicist and structural biologist. He was born in London,U.K. and is a dual U.S./U.K. Citizen. He is a Member of the National Academy of Sciences,a Fellow of the Royal Society,a NIH Distinguished Investigator,and the Chief of the Molecular and Structural Biophysics Section in the Laboratory of Chemical Physics of the National Institute of Diabetes and Digestive and Kidney Diseases at the U.S. National Institutes of Health. He is known for his foundational work in three-dimensional protein and nucleic acid structure determination by biomolecular NMR spectroscopy,for advancing experimental approaches to the study of large macromolecules and their complexes by NMR,and for developing NMR-based methods to study rare conformational states in protein-nucleic acid and protein-protein recognition. Clore's discovery of previously undetectable,functionally significant,rare transient states of macromolecules has yielded fundamental new insights into the mechanisms of important biological processes,and in particular the significance of weak interactions and the mechanisms whereby the opposing constraints of speed and specificity are optimized. Further,Clore's work opens up a new era of pharmacology and drug design as it is now possible to target structures and conformations that have been heretofore unseen.
Carl O. Pabo is a biophysicist. He is the founder and president of Humanity 2050,a nonprofit institute.